Evidence map›Paper›PMID 24550993›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2014

Effects of a Proprietary Freeze-Dried Water Extract of Eurycoma longifolia (Physta) and Polygonum minus on Sexual Performance and Well-Being in Men: A Randomized, Double-Blind, Placebo-Controlled Study.

Jay K Udani, Annie A George, Mufiza Musthapa, Michael N Pakdaman, Azreena Abas

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Medicina (Kaunas, Lithuania) · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Efficacy and Safety of TESTOPEAKAmerican journal of men's health
    Trial
  5. Review
  6. Eurycomanone fromJournal of clinical biochemistry and nutrition · 2024
    Article
  7. Effects ofBMJ open · 2023
    Article
  8. How Internet Websites Portray Herbal Vitality Products ContainingInternational journal of environmental research and public health · 2022
    Article
  9. Effect ofFood & nutrition research · 2021
    Article
  10. Review
  11. Efficacy and Safety of a Mixed Extract ofThe world journal of men's health · 2018
    Article
  12. Efficacy and safety ofFood & nutrition research · 2018
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jay K UdaniMedicus Research LLC, Northridge, CA 91325, USA ; Northridge Hospital Integrative Medicine Program, Northridge, CA 91325, USA.
Annie A GeorgeBiotropics Malaysia Berhad, Level 52, Menara TM, Jalan Pantai Baharu, 50672 Kuala Lumpur, Malaysia.
Mufiza MusthapaBiotropics Malaysia Berhad, Level 52, Menara TM, Jalan Pantai Baharu, 50672 Kuala Lumpur, Malaysia.
Michael N PakdamanMedicus Research LLC, Northridge, CA 91325, USA.
Azreena AbasBiotropics Malaysia Berhad, Level 52, Menara TM, Jalan Pantai Baharu, 50672 Kuala Lumpur, Malaysia.
Biotropics Malaysia (Malaysia) · MYGamma Medica (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Physta is a proprietary product containing a freeze-dried water extract of Eurycoma longifolia (tongkat ali), which is traditionally used as an energy enhancer and aphrodisiac. We aim to evaluate a 300 mg combination of Physta and Polygonum minus, an antioxidant, with regard to sexual performance and well-being in men. Methods. Men that aged 40-65 years were screened for this 12-week randomized, double-blind, placebo-controlled, parallel-group study. Outcome measures included validated questionnaires that aimed to evaluate erectile function, satisfaction with intervention, sexual intercourse performance, erectile hardness, mood, and overall quality of life. Results. 12 subjects in the active group and 14 in the placebo group completed the study. Significant improvements were noted in scores for the Sexual Intercourse Attempt diary, Erection Hardness Scale, Sexual Health Inventory of Men, and Aging Male Symptom scale (P < 0.05 for all). Three adverse events were reported in the active group and four in the placebo group, none of which were attributed to study product. Laboratory evaluations, including liver and kidney function testing, showed no clinically significant abnormality. Conclusion. Supplementation for twelve weeks with Polygonum minus and the proprietary Eurycoma longifolia extract, Physta, was well tolerated and more effective than placebo in enhancing sexual performance in healthy volunteers.

Identifiers

PMID24550993
PMCPMC3914427
OpenAlexW2027871815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.